Watson, Chris
Spiers, J. Paul
Waterstone, Max
Russell-Hallinan, Adam
Gallagher, Joseph
McDonald, Kenneth
Ryan, Cristin
Gilmer, John
Ledwidge, Mark http://orcid.org/0000-0001-7391-2949
Funding for this research was provided by:
Health Research Board Ireland (HRA POR 2012)
FP7 Health (Health Project 261409)
Article History
Received: 7 July 2020
Accepted: 7 January 2021
First Online: 12 February 2021
Ethics approval and consent to participate
: The STOP-HF follow-up programme was approved by the St Vincent’s University Hospital Ethics Committee and conformed to the principles of the Declaration of Helsinki and all patients enrolled provided written, informed consent for participation in the study. The corresponding author confirms that the consent of all authors has been provided to publish this manuscript.
: Participants in this study have consented to the publication of results in aggregate and have not consented to the publication of individual patient level data.
: Dr Gallagher received payment for lectures from Merck, Servier Laboratories. Pfizer and Grunenthal and travel expenses to meeting from Merck. Prof. Ken McDonald is a named inventor on several patents relating to novel biomarkers of cardiovascular disease. He is also funded by an EU FP7 grant investigating biomarkers of cardiovascular disease and recently by the Health Research Board of Ireland. He had received honoraria from Pfizer, Alere, Menarini, Novartis, Servier and Abbott. Prof. Ledwidge reports board membership and shares in Solvotrin and is a named inventor on several relevant patents relating to absorption of iron, superaspirin effects of isosorbide prodrugs, compounds for treatment of heart failure and epigenetic regulation of cardiomyopathies. He is a Co-Investigator in the PARABLE study, which has received an unrestricted research grant from Novartis. He is principal investigator of the Genuity Science Genomics of Heart Failure study. He has also received honoraria and research grants from A Menarini, Servier and Abbott Diagnostics. No other conflicts of interest were reported.